SCHEMBL6979149

SCHEMBL6979149

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
NR3C1 P04150 1/20 0.38
NOTUM Q6P988 1/20 0.38
TP53 P04637 1/20 0.38
ALDH1A1 P00352 4/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979151 0.87 USP14 (0.35) PARP1NOTUMALDH1A1HPGDMEN1
SCHEMBL6984161 0.87 PARP1 (0.39) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL7958757 0.85 PARP1 (0.42) PARP1NR3C1TP53ALDH1A1HPGD
SCHEMBL6985390 0.84 ALDH1A1 (0.40) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL6982684 0.83 KDM1A (0.43) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL7958945 0.82 PDK1 (0.41) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL6985609 0.81 NOTUM (0.39) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL6987763 0.81 NR3C1 (0.47) NR3C1ALDH1A1HPGDUSP2MAPT
SCHEMBL6980751 0.80 NOTUM (0.44) PARP1NR3C1NOTUMTP53ALDH1A1
SCHEMBL6982826 0.79 P2RX7 (0.41) PARP1NR3C1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed